1. OC-0129 Adaptive Dose Painting vs standard IMRT in a randomized phase II trial: a dosimetric analysis. (May 2022) Authors: Vercauteren, T.; De Bruycker, A.; Duprez, F.; Daisne, J.; Olteanu, A.M.L.; Deheneffe, S.; Berwouts, D.; De Neve, W.; Madani, I.; Paelinck, L.; Speleers, B.; Goethals, I.; De Gersem, W. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0370: Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer (STOMP). (November 2020) Authors: Ost, P.; Reynders, D.; Decaestecker, K.; Fonteyne, V.; Lumen, N.; De Bruycker, A.; Lambert, B.; Delrue, L.; Bultijnck, R.; Goetghebeur, E.; Villeirs, G.; De Man, K.; Ameye, F.; Billiet, I.; Joniau, S.; Vanhaverbeke, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SP-0375: Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence. (April 2018) Authors: Ost, P.; Reynders, D.; Decaestecker, K.; Fonteyne, V.; Lumen, N.; De Bruycker, A.; Lambert, B.; Delrue, L.; Bultijnck, R.; Goetghebeur, E.; De Man, K.; De Meerleer, G. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗